In the wake of President-elect Donald Trump's bold statements on the pharmaceutical industry, healthcare and pharma stocks have taken a significant hit. Trump’s promise to tackle drug-industry middlemen, particularly Pharmacy Benefit Managers (PBMs), has sent ripples...
SEC Rescinds Controversial Rule on Crypto Assets
The U.S. Securities and Exchange Commission (SEC) has rescinded a controversial accounting rule that required banks to treat bitcoin and other cryptocurrencies as liabilities on their balance sheets. Staff Accounting Bulletin 121 (SAB 121), introduced in 2022, imposed...
Novo Nordisk Soars 12% With Ozempic Alternative
Novo Nordisk (NVO) experienced a significant surge in pre-market trading on Friday, with its stock climbing 12% following the announcement of promising results from an early-stage clinical trial for its new obesity treatment, amycretin. The Danish pharmaceutical giant...
Saudi Crown Prince Bets Big: $600 Billion Investment
In a move that highlights Saudi Arabia’s ongoing efforts to strengthen its economic ties with the United States, Crown Prince Mohammed bin Salman (MBS) announced a significant pledge to President Donald Trump. According to the Saudi state-run news agency SPA, MBS...